These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 8118936)

  • 1. Promotion of preneoplastic foci in rat liver with 2,3,7,8-tetrachlorodibenzo-p-dioxin, 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin and a defined mixture of 49 polychlorinated dibenzo-p-dioxins.
    Schrenk D; Buchmann A; Dietz K; Lipp HP; Brunner H; Sirma H; Münzel P; Hagenmaier H; Gebhardt R; Bock KW
    Carcinogenesis; 1994 Mar; 15(3):509-15. PubMed ID: 8118936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue concentrations and induction of a hepatic monooxygenase in male Wistar rats after repeated doses of defined polychlorinated dibenzo-p-dioxin and dibenzofuran (PCDDs and PCDFs) mixtures.
    Körner W; Golor G; Schulz T; Wiesmüller T; Hagenmaier H; Neubert D
    Arch Toxicol; 2002 Jan; 75(11-12):653-64. PubMed ID: 11876498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of altered hepatic foci by a mixture of dioxin-like compounds with and without 2,2',4,4',5,5'-hexachlorobiphenyl in female Sprague-Dawley rats.
    van der Plas SA; Haag-Grönlund M; Scheu G; Wärngård L; van den Berg M; Wester P; Koeman JH; Brouwer A
    Toxicol Appl Pharmacol; 1999 Apr; 156(1):30-9. PubMed ID: 10101096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of 2,3,7,8-tetrachloro- and 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin on the proliferation of preneoplastic liver cells in the rat.
    Buchmann A; Stinchcombe S; Körner W; Hagenmaier H; Bock KW
    Carcinogenesis; 1994 Jun; 15(6):1143-50. PubMed ID: 8020147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rainbow trout hepatic mixed-function oxygenase induction by polychlorinated dibenzo-p-dioxins (PCDDs) as a function of time and tissue concentration.
    Parrott JL; Hodson PV; Dixon DG
    J Toxicol Environ Health; 1995 Nov; 46(3):301-16. PubMed ID: 7473859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subchronic/chronic toxicity of 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin (HpCDD) in rats. Part II. Biochemical effects.
    Viluksela M; Stahl BU; Birnbaum LS; Rozman KK
    Toxicol Appl Pharmacol; 1997 Oct; 146(2):217-26. PubMed ID: 9344889
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocarcinogenesis in female Sprague-Dawley rats following discontinuous treatment with 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Walker NJ; Tritscher AM; Sills RC; Lucier GW; Portier CJ
    Toxicol Sci; 2000 Apr; 54(2):330-7. PubMed ID: 10774815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian hormones enhance 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated increases in cell proliferation and preneoplastic foci in a two-stage model for rat hepatocarcinogenesis.
    Lucier GW; Tritscher A; Goldsworthy T; Foley J; Clark G; Goldstein J; Maronpot R
    Cancer Res; 1991 Mar; 51(5):1391-7. PubMed ID: 1671757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Promotion of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p-dioxin and 17beta-estradiol in male Sprague-Dawley rats.
    Wyde ME; Cambre T; Lebetkin M; Eldridge SR; Walker NJ
    Toxicol Sci; 2002 Aug; 68(2):295-303. PubMed ID: 12151625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Apr; (521):4-232. PubMed ID: 16835633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships and dose responses of polychlorinated dibenzo-p-dioxins for short-term effects in 2,3,7,8-tetrachlorodibenzo-p-dioxin-resistant and -sensitive rat strains.
    Simanainen U; Tuomisto JT; Tuomisto J; Viluksela M
    Toxicol Appl Pharmacol; 2002 May; 181(1):38-47. PubMed ID: 12030841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of dose- and time-dependent promotion of four phenotypes of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p-dioxin in female Sprague-Dawley rats.
    Teeguarden JG; Dragan YP; Singh J; Vaughan J; Xu YH; Goldsworthy T; Pitot HC
    Toxicol Sci; 1999 Oct; 51(2):211-23. PubMed ID: 10543023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response relationships for chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin in a rat tumor promotion model: quantification and immunolocalization of CYP1A1 and CYP1A2 in the liver.
    Tritscher AM; Goldstein JA; Portier CJ; McCoy Z; Clark GC; Lucier GW
    Cancer Res; 1992 Jun; 52(12):3436-42. PubMed ID: 1596902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of enzyme-altered liver foci in rats initiated with diethylnitrosamine and promoted with 2,3,7,8-tetrachlorodibenzo-p-dioxin or 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin.
    Moolgavkar SH; Luebeck EG; Buchmann A; Bock KW
    Toxicol Appl Pharmacol; 1996 May; 138(1):31-42. PubMed ID: 8658510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on I-compounds in hepatic DNA of Sprague-Dawley rats: sex-specific effects and structure-activity relationships.
    Randerath K; Putman KL; Randerath E; Zacharewski T; Harris M; Safe S
    Toxicol Appl Pharmacol; 1990 Apr; 103(2):271-80. PubMed ID: 2158676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of planar (0-1 ortho) and nonplanar (2-4 ortho) fractions of Aroclor 1260 to the induction of altered hepatic foci in female Sprague-Dawley rats.
    van der Plas SA; Sundberg H; van den Berg H; Scheu G; Wester P; Jensen S; Bergman A; de Boer J; Koeman JH; Brouwer A
    Toxicol Appl Pharmacol; 2000 Dec; 169(3):255-68. PubMed ID: 11133348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxicology and carcinogenesis studies of a mixture of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (Cas No. 1746-01-6), 2,3,4,7,8-pentachlorodibenzofuran (PeCDF) (Cas No. 57117-31-4), and 3,3',4,4',5-pentachlorobiphenyl (PCB 126) (Cas No. 57465-28-8) in female Harlan Sprague-Dawley rats (gavage studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2006 Sep; (526):1-180. PubMed ID: 17342195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative potency based on hepatic enzyme induction predicts immunosuppressive effects of a mixture of PCDDS/PCDFS and PCBS.
    Smialowicz RJ; DeVito MJ; Williams WC; Birnbaum LS
    Toxicol Appl Pharmacol; 2008 Mar; 227(3):477-84. PubMed ID: 18190939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levels of PCDDs, PCDFs, and dioxin-like PCBs in human milk among Hong Kong mothers.
    Wong TW; Wong AH; Nelson EA; Qiu H; Ku SY
    Sci Total Environ; 2013 Oct; 463-464():1230-8. PubMed ID: 22939609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Persistence of TCDD-induced hepatic cell proliferation and growth of enzyme altered foci after chronic exposure followed by cessation of treatment in DEN initiated female rats.
    Tritscher AM; Clark GC; Sewall C; Sills RC; Maronpot R; Lucier GW
    Carcinogenesis; 1995 Nov; 16(11):2807-11. PubMed ID: 7586202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.